Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.
See previous edition Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Research
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases (original read.)
A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes (original read.)
The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov (original read.)
Acute Adverse Effects of Therapeutic Doses of Psilocybin – A Systematic Review and Meta-Analysis (original read.)
Tune In, Get Smart
What psychedelics legalization and decriminalization looks like around the world, by BBC’s Jennifer Chesak.
Global Perspectives on Psychedelics Regulation, by The Regulatory Review.
Why Psychedelic Therapy Needs Specially Trained Therapists, by Psychology Today.
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use, research published in Drug Science.
Psychedelic Church Sues for Defamation After Lab Test Raises Hope for Presence of Novel Drug, by Mattha Busby for DoubleBlind.
William James was right about our strange inner experiences, writes renowned researcher David Yaden for Psyche.
Psychedelic music depicted on …